Keywords: |
immunohistochemistry; platelet derived growth factor; vasculotropin; gene mutation; somatic mutation; clinical feature; review; cancer growth; cancer staging; neoplasm staging; cancer grading; antigen expression; genetic predisposition to disease; gene expression; cell maturation; cystadenoma; lipid; pathology; histology; morphology; oncocytoma; renal cell carcinoma; kidney carcinoma; adenoma, oxyphilic; kidney neoplasms; fluorescence in situ hybridization; metanephric adenoma; kidney adenoma; carbonate dehydratase ix; carcinoma, renal cell; needle biopsy; chromosome translocation; translocation, genetic; fibroma; world health organization; familial cancer; clear cell carcinoma; cytokeratin 7; adenocarcinoma, clear cell; papillary carcinoma; cytokeratin; kidney pelvis carcinoma; spindle cell carcinoma; chromosome analysis; comparative genomic hybridization; adenocarcinoma, papillary; kidney biopsy; von hippel lindau protein; acinar cell; mucinous carcinoma; glucose transporter 1; scatter factor receptor; medullary carcinoma; carcinoma, medullary; kidney collecting tubule; kidney cortex; collecting duct carcinoma; hypoxia inducible factor 1; granular cell tumor; chromophobe renal cell carcinoma; kidney sarcoma; adenoma, chromophobe; glycogen; kidney diseases, cystic; morphologic features; agglutinin; antigenicity; metanephric adenofibroma; multiocular cystic renal cell carcinoma; renal oncocytoma; tubulocystic renal cell carcinoma; kidney tubules, collecting
|